Joleen M Hubbard, MD

  • 637 Citations
  • 14 Scopus h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Joleen M Hubbard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
Antineoplastic Combined Chemotherapy Protocols Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Biological Factors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 637 Citations
  • 14 Scopus h-Index
  • 42 Article
  • 6 Review article
  • 5 Chapter

Arti Hurria, M.D. A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology

On behalf of the Alliance Cancer in the Older Adult Committee, Jan 1 2019, In : Journal of Geriatric Oncology.

Research output: Contribution to journalReview article

Clinical Trials

A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer

Sonbol, M. B., Benkhadra, R., Wang, Z., Firwana, B., Walden, D. J., Mody, K., Hubbard, J. M., Murad, M. H., Ahn, D. & Bekaii-Saab, T., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalReview article

Colorectal Neoplasms
Disease-Free Survival
Survival
irinotecan
oxaliplatin
1 Citation (Scopus)

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

Kommalapati, A., Tella, S. H., Goyal, G., Borad, M. J., Alberts, S. R., Roberts, L. R., Hubbard, J. M., Durgin, L., Cleary, S. & Mahipal, A., Jan 1 2018, (Accepted/In press) In : HPB.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Survival
Liver
Therapeutics
Insurance

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

Duma, N., Kothadia, S. M., Azam, T. U., Yadav, S., Paludo, J., Vera Aguilera, J., Gonzalez Velez, M., Halfdanarson, T. R., Molina, J. R., Hubbard, J. M., Go, R. S., Mansfield, A. & Adjei, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Patient Selection
Comorbidity
Clinical Trials
Central Nervous System
Neoplasm Metastasis
5 Citations (Scopus)

Clinical update on K-Ras targeted therapy in gastrointestinal cancers

Pant, S., Hubbard, J. M., Martinelli, E. & Bekaii-Saab, T., Oct 1 2018, In : Critical Reviews in Oncology/Hematology. 130, p. 78-91 14 p.

Research output: Contribution to journalReview article

Gastrointestinal Neoplasms
Antisense Oligonucleotides
Protein Transport
Mitogen-Activated Protein Kinases
Pancreatic Neoplasms